AUSTAR(06118),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06118 AUSTAR

Closed 03-27 16:08:18

0.810

+0.090

+12.50%

High0.970	Low0.700	Vol1.95M
Open0.700	D1 Closing0.720	Amplitude37.50%
Mkt Cap415.53M	Tradable Cap415.19M	Total Shares513.00M
T/O1.65M	T/O Rate0.38%	Tradable Shares512.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06118","market":"HK","secType":"STK","nameCN":"AUSTAR","latestPrice":0.81,"timestamp":1774598898961,"preClose":0.72,"halted":0,"volume":1954000,"delay":0,"changeRate":0.1250000000000001,"floatShares":512582000,"shares":513000000,"eps":0.031368,"marketStatus":"Closed","change":0.09,"latestTime":"03-27 16:08:18","open":0.7,"high":0.97,"low":0.7,"amount":1652510,"amplitude":0.375,"askPrice":0.85,"askSize":23000,"bidPrice":0.81,"bidSize":202000,"shortable":0,"etf":0,"ttmEps":0.075251,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":5,"adr":0,"listingDate":1415289600000,"exchange":"SEHK","adjPreClose":0.72,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"volumeRatio":12.974768,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06118/wiki","defaultTab":"wiki","newsList":[{"id":"1164078913","title":"AUSTAR Life Sciences (06118) Reports 2025 Financial Results: Profit Attributable to Owners Surges 110.24% to RMB33.81 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1164078913","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164078913?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:38","pubTimestamp":1774539498,"startTime":"0","endTime":"0","summary":"AUSTAR Life Sciences (06118) has announced its financial results for 2025. The company reported revenue of approximately RMB1.531 billion, representing a year-on-year increase of about 2%. Profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118","BK1141"],"gpt_icon":0},{"id":"2622886481","title":"BRIEF-Austar Lifesciences Posts FY Revenue RMB 1,530.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622886481","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622886481?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:23","pubTimestamp":1774538638,"startTime":"0","endTime":"0","summary":"BRIEF-Austar Lifesciences Posts FY Revenue RMB 1,530.7 MillionMarch 26 (Reuters) - Austar Lifesciences 6118.HK:FY REVENUE RMB 1,530.7 MILLIONPROFIT FOR YEAR ATTRIBUTABLE RMB33.8 MILLIONFurther company coverage: 6118.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX72D084:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118","BK1141"],"gpt_icon":0},{"id":"1139110773","title":"Austar Lifesciences’ 2025 Net Profit Jumps 142.30%, Revenue Reaches RMB 1.53 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1139110773","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139110773?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:05","pubTimestamp":1774537554,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited reported a strong earnings rebound for the year ended 31 December 2025, with profit more than doubling despite a slight contraction in gross margin. Key Financials (YoY) •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"gpt_icon":0},{"id":"2622869146","title":"Austar Lifesciences - Profit for Year Attributable RMB33.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622869146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622869146?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:43","pubTimestamp":1774536180,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX72D084:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","06118"],"gpt_icon":0},{"id":"2622854280","title":"Austar Lifesciences proposes articles of association amendments; shareholder vote set for May 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622854280","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622854280?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:29","pubTimestamp":1774524582,"startTime":"0","endTime":"0","summary":"Austar Lifesciences announced proposed amendments to its articles of association to align with updated Hong Kong Listing Rules requirements.The changes would add provisions to allow the company to hold treasury shares.Shareholders would be able to give instructions and receive corporate action proceeds by electronic means.The amendments would also add provisions for holding and transferring shares in uncertificated form.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Austar Lifesciences Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL20ZmP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06118"],"gpt_icon":0},{"id":"1190363908","title":"Austar Lifesciences (06118) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1190363908","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190363908?lang=en_us&edition=fundamental","pubTime":"2026-03-16 17:40","pubTimestamp":1773654059,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (Stock Code: 06118) has announced that its board of directors will convene on 26 March 2026. The agenda includes: • Approval of the consolidated results for the financial...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"gpt_icon":0},{"id":"1144081103","title":"Austar Lifesciences (06118) Announces Monthly Equity Movements for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1144081103","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144081103?lang=en_us&edition=fundamental","pubTime":"2026-03-02 11:41","pubTimestamp":1772422901,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (06118) disclosed its monthly return for equity issuer for the period ended 28 February 2026. The announcement indicates that authorized share capital remained at 10.00...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"gpt_icon":0},{"id":"2609756483","title":"BRIEF-Austar Lifesciences Expects Profit Attributable Of Not Less Than RMB30 Million For FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2609756483","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609756483?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:32","pubTimestamp":1770373976,"startTime":"0","endTime":"0","summary":"BRIEF-Austar Lifesciences Expects Profit Attributable Of Not Less Than RMB30 Million For FYFeb 6  - Austar Lifesciences Ltd 6118.HK:EXPECTS PROFIT ATTRIBUTABLE OF NOT LESS THAN RMB30 MILLION FOR FYEXPECTED FY RESULT DUE TO DECREASE IN OPERATING EXPENSES FROM STRATEGIC EFFICIENCY ENHANCEMENT, OTHERSFurther company coverage: 6118.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z2071:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118","BK1141"],"gpt_icon":0},{"id":"2609376565","title":"Austar Lifesciences Forecasts Higher 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2609376565","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609376565?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:48","pubTimestamp":1770367708,"startTime":"0","endTime":"0","summary":"Austar Lifesciences  expects to record an attributable profit of not less than 30 million yuan for 2025, up from about 16 million yuan a year earlier, according to a Friday Hong Kong bourse filing.The company attributed the increase mainly to lower operating expenses, including reduced administrative and research and development costs, as well as higher other gains, driven largely by exchange gains, and lower finance costs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1141","06118"],"gpt_icon":0},{"id":"1143338277","title":"Austar Lifesciences Limited (6118) Expects Significant Profit Growth for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1143338277","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143338277?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:44","pubTimestamp":1770367499,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (6118) announced a preliminary assessment indicating a profit attributable to owners of not less than RMB30 million for the year ended 31 December 2025, compared with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"gpt_icon":0},{"id":"1122980646","title":"AUSTAR Life Sciences Issues Profit Alert, Anticipates Minimum 30 Million Yuan Net Profit for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1122980646","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122980646?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:38","pubTimestamp":1770367136,"startTime":"0","endTime":"0","summary":"AUSTAR Life Sciences (06118) has announced a positive profit forecast. Based on a preliminary assessment of the group's unaudited consolidated management accounts and currently available information...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06118"],"gpt_icon":0},{"id":"2609563571","title":"Austar Lifesciences Expects 2025 Profit to Surge to Over RMB30 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563571","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563571?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:33","pubTimestamp":1770366810,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Ltd. has announced that it expects to report a profit attributable to owners of not less than RMB30 million for the year ended 31 December 2025. This represents a significant increase compared to the approximately RMB16 million profit recorded for the previous year. The substantial profit growth is primarily attributed to a decrease in operating expenses due to a focus on strategic efficiency and a sustainable model for long-term value creation. The company is in the process of finalising its annual results, which are expected to be announced in late March 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Austar Lifesciences Ltd. published the original content used to generate this news brief via IIS, the Issuer ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDLc33JSp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06118"],"gpt_icon":0},{"id":"2609563599","title":"Austar Lifesciences - Expects Profit Attributable of Not Less Than RMB30 Mln for FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563599?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:32","pubTimestamp":1770366767,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z2071:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","06118"],"gpt_icon":0},{"id":"2609156368","title":"Austar Lifesciences - Expected FY Result Due to Decrease in Operating Expenses From Strategic Efficiency Enhancement, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2609156368","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609156368?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:32","pubTimestamp":1770366767,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z2071:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06118","BK1141"],"gpt_icon":0},{"id":"2583421275","title":"3.0% earnings growth over 5 years has not materialized into gains for Austar Lifesciences (HKG:6118) shareholders over that period","url":"https://stock-news.laohu8.com/highlight/detail?id=2583421275","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583421275?lang=en_us&edition=fundamental","pubTime":"2025-11-14 07:43","pubTimestamp":1763077431,"startTime":"0","endTime":"0","summary":"Long term investing works well, but it doesn't always work for each individual stock. We really hate to see fellow...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6118/austar-lifesciences-shares/news/30-earnings-growth-over-5-years-has-not-materialized-into-ga-2","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6118/austar-lifesciences-shares/news/30-earnings-growth-over-5-years-has-not-materialized-into-ga-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06118"],"gpt_icon":0},{"id":"1163304704","title":"Austar Lifesciences (06118) Reports Unchanged Share Capital and Issued Shares for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1163304704","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163304704?lang=en_us&edition=fundamental","pubTime":"2025-11-03 13:32","pubTimestamp":1762147956,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (Stock Code: 06118) released its monthly return for the period ended 31 October 2025, indicating no changes in its authorized or issued share capital. The total authorized...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"gpt_icon":0},{"id":"2574145303","title":"Austar Lifesciences Limited's (HKG:6118) Share Price Boosted 27% But Its Business Prospects Need A Lift Too","url":"https://stock-news.laohu8.com/highlight/detail?id=2574145303","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574145303?lang=en_us&edition=fundamental","pubTime":"2025-10-10 06:22","pubTimestamp":1760048575,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited ( HKG:6118 ) shares have continued their recent momentum with a 27% gain in the last month...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6118/austar-lifesciences-shares/news/austar-lifesciences-limiteds-hkg6118-share-price-boosted-27","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6118/austar-lifesciences-shares/news/austar-lifesciences-limiteds-hkg6118-share-price-boosted-27","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1141","06118"],"gpt_icon":0},{"id":"1153456278","title":"Hong Kong Stock Alert | AUSTAR (06118) Surges Over 54% in Late Trading as Austar Group Serves as Technology-Based Pharmaceutical Engineering Solutions Provider","url":"https://stock-news.laohu8.com/highlight/detail?id=1153456278","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153456278?lang=en_us&edition=fundamental","pubTime":"2025-10-09 16:05","pubTimestamp":1759997125,"startTime":"0","endTime":"0","summary":"AUSTAR (06118) saw its gains expand to over 54% in late trading session. As of press time, the stock was up 48.04% to HK$1.51, with trading volume reaching HK$8.4778 million. According to public...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","YANG","06118","BK1141","07226","BK1574","BK1191","01477","BK4614"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.austar.com.hk","stockEarnings":[{"period":"1week","weight":0.0286},{"period":"1month","weight":-0.1429},{"period":"3month","weight":-0.234},{"period":"6month","weight":-0.301},{"period":"1year","weight":-0.122},{"period":"ytd","weight":-0.1724}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":-0.0652},{"period":"3month","weight":-0.0373},{"period":"6month","weight":-0.0487},{"period":"1year","weight":0.0585},{"period":"ytd","weight":-0.0302}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Austar Lifesciences Ltd is a holding company that mainly engaged in providing integrated engineering solutions, and manufacturing and distributing pharmaceutical equipment and consumables. The Company operates six segments: Fluid and Bioprocess Systems segment, Cleanroom and Automation Control and Monitoring Systems segment, Powder and Solid Systems segment, GMP Compliance Services segment, Life Science Consumables segment, and Distribution and Agency of Pharmaceutical Equipment segment. The Company's products include clean utility equipment and systems, bioprocess equipment and systems, powder and solid equipment and systems, pharmaceutical process contamination control products, packaging and closed transport products, biosafety and laboratory animal equipment and consumables, and others.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.045281},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.021974},{"month":3,"riseRate":0.666667,"avgChangeRate":0.022822},{"month":4,"riseRate":0.545455,"avgChangeRate":0.055171},{"month":5,"riseRate":0.545455,"avgChangeRate":0.032698},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.052675},{"month":7,"riseRate":0.545455,"avgChangeRate":0.186855},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.055211},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.017498},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.032782},{"month":11,"riseRate":0.545455,"avgChangeRate":0.084856},{"month":12,"riseRate":0.416667,"avgChangeRate":0.024928}],"exchange":"SEHK","name":"AUSTAR","nameEN":"AUSTAR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AUSTAR(06118),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest AUSTAR(06118) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"AUSTAR,06118,AUSTAR股票,AUSTAR股票老虎,AUSTAR股票老虎国际,AUSTAR行情,AUSTAR股票行情,AUSTAR股价,AUSTAR股市,AUSTAR股票价格,AUSTAR股票交易,AUSTAR股票购买,AUSTAR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AUSTAR(06118),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest AUSTAR(06118) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}